Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the webspellchecker domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/gulfindex35/public_html/ptbreports.org/wp-includes/functions.php on line 6131
Drug Review: Rezafungin – PTB Reports
Article

Drug Review: Rezafungin

Written by admin

PTB Reports, 2024, 10, 4, 118-119.
DOI: 10.71092/PTB.2024.10.24
Published: December 2024
Type: Drug Review
Authors: Juman Alsaab

 

Author(s) affiliations:

Juman Alsaab, Pharm D, Ministry of Health, Riyadh, SAUDI ARABIA.

Abstract

Regulations: They have been registered in the following countries: the United States of America (USA) and the European Union (E.U.).
General Information:
Registered Company: Melinta Therapeutics.
Regulatory Status: R.X.
Mechanism of Action: inhibits the 1,3-beta-D-glucan synthase enzyme complex in fungal cell walls.
Read More…

Leave a Reply

Your email address will not be published. Required fields are marked *